دورية أكاديمية

Associations Between Ultra-Processed Food Consumption and Adverse Brain Health Outcomes.

التفاصيل البيبلوغرافية
العنوان: Associations Between Ultra-Processed Food Consumption and Adverse Brain Health Outcomes.
المؤلفون: Bhave VM; From the Harvard Medical School (V.M.B., W.T.K.), Boston, MA; Equity Research and Innovation Center (C.R.O.), Yale School of Medicine, New Haven, CT; Center for Genomic Medicine (Z.A., N.K., W.T.K.) and Department of Neurology (Z.A., N.K., A.-L.G.G., W.T.K.), Massachusetts General Hospital, Boston; Division of Neurology (N.K.), Department of Medicine and Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Departments of Epidemiology (A.C.J., C.A.C., A.P., M.R.I.) and Biostatistics (A.B.), School of Public Health, and Department of Psychology (M.C.), University of Alabama at Birmingham., Oladele CR; From the Harvard Medical School (V.M.B., W.T.K.), Boston, MA; Equity Research and Innovation Center (C.R.O.), Yale School of Medicine, New Haven, CT; Center for Genomic Medicine (Z.A., N.K., W.T.K.) and Department of Neurology (Z.A., N.K., A.-L.G.G., W.T.K.), Massachusetts General Hospital, Boston; Division of Neurology (N.K.), Department of Medicine and Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Departments of Epidemiology (A.C.J., C.A.C., A.P., M.R.I.) and Biostatistics (A.B.), School of Public Health, and Department of Psychology (M.C.), University of Alabama at Birmingham., Ament Z; From the Harvard Medical School (V.M.B., W.T.K.), Boston, MA; Equity Research and Innovation Center (C.R.O.), Yale School of Medicine, New Haven, CT; Center for Genomic Medicine (Z.A., N.K., W.T.K.) and Department of Neurology (Z.A., N.K., A.-L.G.G., W.T.K.), Massachusetts General Hospital, Boston; Division of Neurology (N.K.), Department of Medicine and Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Departments of Epidemiology (A.C.J., C.A.C., A.P., M.R.I.) and Biostatistics (A.B.), School of Public Health, and Department of Psychology (M.C.), University of Alabama at Birmingham., Kijpaisalratana N; From the Harvard Medical School (V.M.B., W.T.K.), Boston, MA; Equity Research and Innovation Center (C.R.O.), Yale School of Medicine, New Haven, CT; Center for Genomic Medicine (Z.A., N.K., W.T.K.) and Department of Neurology (Z.A., N.K., A.-L.G.G., W.T.K.), Massachusetts General Hospital, Boston; Division of Neurology (N.K.), Department of Medicine and Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Departments of Epidemiology (A.C.J., C.A.C., A.P., M.R.I.) and Biostatistics (A.B.), School of Public Health, and Department of Psychology (M.C.), University of Alabama at Birmingham., Jones AC; From the Harvard Medical School (V.M.B., W.T.K.), Boston, MA; Equity Research and Innovation Center (C.R.O.), Yale School of Medicine, New Haven, CT; Center for Genomic Medicine (Z.A., N.K., W.T.K.) and Department of Neurology (Z.A., N.K., A.-L.G.G., W.T.K.), Massachusetts General Hospital, Boston; Division of Neurology (N.K.), Department of Medicine and Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Departments of Epidemiology (A.C.J., C.A.C., A.P., M.R.I.) and Biostatistics (A.B.), School of Public Health, and Department of Psychology (M.C.), University of Alabama at Birmingham., Couch CA; From the Harvard Medical School (V.M.B., W.T.K.), Boston, MA; Equity Research and Innovation Center (C.R.O.), Yale School of Medicine, New Haven, CT; Center for Genomic Medicine (Z.A., N.K., W.T.K.) and Department of Neurology (Z.A., N.K., A.-L.G.G., W.T.K.), Massachusetts General Hospital, Boston; Division of Neurology (N.K.), Department of Medicine and Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Departments of Epidemiology (A.C.J., C.A.C., A.P., M.R.I.) and Biostatistics (A.B.), School of Public Health, and Department of Psychology (M.C.), University of Alabama at Birmingham., Patki A; From the Harvard Medical School (V.M.B., W.T.K.), Boston, MA; Equity Research and Innovation Center (C.R.O.), Yale School of Medicine, New Haven, CT; Center for Genomic Medicine (Z.A., N.K., W.T.K.) and Department of Neurology (Z.A., N.K., A.-L.G.G., W.T.K.), Massachusetts General Hospital, Boston; Division of Neurology (N.K.), Department of Medicine and Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Departments of Epidemiology (A.C.J., C.A.C., A.P., M.R.I.) and Biostatistics (A.B.), School of Public Health, and Department of Psychology (M.C.), University of Alabama at Birmingham., Garcia Guarniz AL; From the Harvard Medical School (V.M.B., W.T.K.), Boston, MA; Equity Research and Innovation Center (C.R.O.), Yale School of Medicine, New Haven, CT; Center for Genomic Medicine (Z.A., N.K., W.T.K.) and Department of Neurology (Z.A., N.K., A.-L.G.G., W.T.K.), Massachusetts General Hospital, Boston; Division of Neurology (N.K.), Department of Medicine and Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Departments of Epidemiology (A.C.J., C.A.C., A.P., M.R.I.) and Biostatistics (A.B.), School of Public Health, and Department of Psychology (M.C.), University of Alabama at Birmingham., Bennett A; From the Harvard Medical School (V.M.B., W.T.K.), Boston, MA; Equity Research and Innovation Center (C.R.O.), Yale School of Medicine, New Haven, CT; Center for Genomic Medicine (Z.A., N.K., W.T.K.) and Department of Neurology (Z.A., N.K., A.-L.G.G., W.T.K.), Massachusetts General Hospital, Boston; Division of Neurology (N.K.), Department of Medicine and Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Departments of Epidemiology (A.C.J., C.A.C., A.P., M.R.I.) and Biostatistics (A.B.), School of Public Health, and Department of Psychology (M.C.), University of Alabama at Birmingham., Crowe M; From the Harvard Medical School (V.M.B., W.T.K.), Boston, MA; Equity Research and Innovation Center (C.R.O.), Yale School of Medicine, New Haven, CT; Center for Genomic Medicine (Z.A., N.K., W.T.K.) and Department of Neurology (Z.A., N.K., A.-L.G.G., W.T.K.), Massachusetts General Hospital, Boston; Division of Neurology (N.K.), Department of Medicine and Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Departments of Epidemiology (A.C.J., C.A.C., A.P., M.R.I.) and Biostatistics (A.B.), School of Public Health, and Department of Psychology (M.C.), University of Alabama at Birmingham., Irvin MR; From the Harvard Medical School (V.M.B., W.T.K.), Boston, MA; Equity Research and Innovation Center (C.R.O.), Yale School of Medicine, New Haven, CT; Center for Genomic Medicine (Z.A., N.K., W.T.K.) and Department of Neurology (Z.A., N.K., A.-L.G.G., W.T.K.), Massachusetts General Hospital, Boston; Division of Neurology (N.K.), Department of Medicine and Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Departments of Epidemiology (A.C.J., C.A.C., A.P., M.R.I.) and Biostatistics (A.B.), School of Public Health, and Department of Psychology (M.C.), University of Alabama at Birmingham., Kimberly WT; From the Harvard Medical School (V.M.B., W.T.K.), Boston, MA; Equity Research and Innovation Center (C.R.O.), Yale School of Medicine, New Haven, CT; Center for Genomic Medicine (Z.A., N.K., W.T.K.) and Department of Neurology (Z.A., N.K., A.-L.G.G., W.T.K.), Massachusetts General Hospital, Boston; Division of Neurology (N.K.), Department of Medicine and Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Departments of Epidemiology (A.C.J., C.A.C., A.P., M.R.I.) and Biostatistics (A.B.), School of Public Health, and Department of Psychology (M.C.), University of Alabama at Birmingham.
المصدر: Neurology [Neurology] 2024 Jun 11; Vol. 102 (11), pp. e209432. Date of Electronic Publication: 2024 May 22.
نوع المنشور: Journal Article; Observational Study
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE
أسماء مطبوعة: Publication: Hagerstown, MD : Lippincott Williams & Wilkins
Original Publication: Minneapolis.
مواضيع طبية MeSH: Stroke*/epidemiology , Stroke*/prevention & control , Fast Foods*/adverse effects, Humans ; Female ; Male ; Middle Aged ; Aged ; Prospective Studies ; White People ; United States/epidemiology ; Diet, Mediterranean ; Cognitive Dysfunction/epidemiology ; Cognitive Dysfunction/etiology ; Cohort Studies ; Dietary Approaches To Stop Hypertension ; Incidence ; Risk Factors ; Adult ; Food Handling ; Food, Processed
مستخلص: Background and Objectives: Ultra-processed foods (UPFs) are linked to cardiometabolic diseases and neurologic outcomes, such as cognitive decline and stroke. However, it is unclear whether food processing confers neurologic risk independent of dietary pattern information. We aimed to (1) investigate associations between UPFs and incident cognitive impairment and stroke and (2) compare these associations with other commonly recommended dietary patterns in the REasons for Geographic and Racial Differences in Stroke study. This prospective, observational cohort study enrolled Black and White adults in the United States from 2003 to 2007.
Methods: The NOVA system was used to categorize items from a baseline food frequency questionnaire according to the level of processing. Participants with incomplete or implausible self-reported dietary data were excluded. Consumption for each category (grams) was normalized to total grams consumed. Scores quantifying adherence to a Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet were also calculated. Incident cognitive impairment was defined using performance relative to a normative sample on memory and fluency assessments. Incident stroke was identified through adjudicated review of medical records.
Results: The cognitive impairment cohort (n = 14,175) included participants without evidence of impairment at baseline who underwent follow-up testing. The stroke cohort (n = 20,243) included participants without a history of stroke. In multivariable Cox proportional hazards models, a 10% increase in relative intake of UPFs was associated with higher risk of cognitive impairment (hazard ratio [HR] = 1.16, 95% CI 1.09-1.24, p = 1.01 × 10 -5 ) and intake of unprocessed or minimally processed foods with lower risk of cognitive impairment (HR = 0.88, 95% CI 0.83-0.94, p = 1.83 × 10 -4 ). Greater intake of UPFs (HR = 1.08, 95% CI 1.02-1.14, p = 1.12 × 10 -2 ) and unprocessed or minimally processed foods (HR = 0.91, 95% CI 0.86-0.95, p = 2.13 × 10 -4 ) were also associated with risk of stroke in multivariable Cox models. The effect of UPFs on stroke risk was greater among Black than White participants (UPF-by-race interaction HR = 1.15, 95% CI 1.03-1.29, p = 1.50 × 10 -2 ). Associations between UPFs and both cognitive impairment and stroke were independent of adherence to the Mediterranean, DASH, and MIND diets.
Discussion: Food processing may be important to brain health in older adults independent of known risk factors and adherence to recommended dietary patterns.
References: Public Health Nutr. 2019 Apr;22(5):936-941. (PMID: 30744710)
JAMA Intern Med. 2015 Jul;175(7):1094-1103. (PMID: 25961184)
Ann Neurol. 2013 Oct;74(4):580-91. (PMID: 23720230)
EClinicalMedicine. 2023 Jan 31;56:101840. (PMID: 36880051)
JAMA Intern Med. 2013 Jan 14;173(1):46-51. (PMID: 23229778)
Stroke. 2018 Apr;49(4):987-994. (PMID: 29581343)
JAMA Psychiatry. 2023 Jun 1;80(6):630-638. (PMID: 37133875)
Ann Neurol. 2011 Apr;69(4):619-27. (PMID: 21416498)
Stroke. 2013 Dec;44(12):3305-11. (PMID: 24159061)
Am J Clin Nutr. 2022 Jan 11;115(1):211-221. (PMID: 34647997)
BMJ. 2019 May 29;365:l1451. (PMID: 31142457)
Alzheimers Dement. 2015 Sep;11(9):1015-22. (PMID: 26086182)
Neurology. 2014 Sep 30;83(14):1271-6. (PMID: 25209581)
Arch Intern Med. 2008 Apr 14;168(7):713-20. (PMID: 18413553)
JAMA Neurol. 2023 Feb 1;80(2):142-150. (PMID: 36469335)
Arch Neurol. 2007 May;64(5):725-30. (PMID: 17502472)
Nutrition. 2013 Apr;29(4):611-8. (PMID: 23466047)
Stroke. 2016 Apr;47(4):986-90. (PMID: 26869384)
Ann Neurol. 2023 Mar;93(3):500-510. (PMID: 36373825)
Eur J Nutr. 2019 Feb;58(1):173-191. (PMID: 29177567)
Br J Nutr. 2021 Feb 14;125(3):308-318. (PMID: 32792031)
J Prev Alzheimers Dis. 2019;6(4):267-273. (PMID: 31686099)
Stroke. 1989 Oct;20(10):1407-31. (PMID: 2799873)
Alzheimers Dement. 2015 Sep;11(9):1007-14. (PMID: 25681666)
JAMA Netw Open. 2019 May 3;2(5):e193121. (PMID: 31099861)
Stroke. 1991 Mar;22(3):312-8. (PMID: 2003301)
Neurology. 2022 Sep 6;99(10):e1056-e1066. (PMID: 36219796)
Neurology. 2016 Feb 16;86(7):637-42. (PMID: 26791153)
Neurology. 2013 Apr 30;80(18):1684-92. (PMID: 23628929)
Adv Nutr. 2019 Nov 1;10(6):1040-1065. (PMID: 31209456)
J Nutr. 2015 Dec;145(12):2639-45. (PMID: 26468491)
J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1318-25. (PMID: 23670794)
Am J Epidemiol. 2017 Nov 1;186(9):1026-1034. (PMID: 28641372)
Clin Neuropsychol. 2015;29(4):466-86. (PMID: 25978342)
N Engl J Med. 2023 Aug 17;389(7):602-611. (PMID: 37466280)
Lancet Neurol. 2020 Mar;19(3):255-265. (PMID: 31813850)
Neuroepidemiology. 2005;25(3):135-43. (PMID: 15990444)
Am J Clin Nutr. 2021 Feb 2;113(2):446-455. (PMID: 33333551)
Med Care. 2002 Sep;40(9):771-81. (PMID: 12218768)
Stroke. 2015 Mar;46(3):780-5. (PMID: 25628306)
JAMA Intern Med. 2020 Feb 1;180(2):283-291. (PMID: 31841598)
JAMA. 2018 Oct 2;320(13):1338-1348. (PMID: 30285178)
Front Nutr. 2015 Jan 19;1:29. (PMID: 25988129)
تواريخ الأحداث: Date Created: 20240522 Date Completed: 20240522 Latest Revision: 20240615
رمز التحديث: 20240615
مُعرف محوري في PubMed: PMC11175629
DOI: 10.1212/WNL.0000000000209432
PMID: 38776524
قاعدة البيانات: MEDLINE
الوصف
تدمد:1526-632X
DOI:10.1212/WNL.0000000000209432